Rapamycin-induced inhibition of HTLV-I LTR activity is rescued by c-Myb

Retrovirology

Volumn 4, Issue , 2007, Pages

  Rose, Nicola J ^a   Lever, Andrew M L ^b  

^a NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; PROTEIN C MYB; RAPAMYCIN; TACROLIMUS; TAX PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ETS; TRANSCRIPTION FACTOR ETS 1; TRANSCRIPTION FACTOR ETS 2; CHLORAMPHENICOL ACETYLTRANSFERASE;

5' UNTRANSLATED REGION; ANTIBIOTIC SENSITIVITY; ANTIVIRAL ACTIVITY; ARTICLE; COMBINATION CHEMOTHERAPY; COMPLEX FORMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DELETION MUTANT; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN T CELL LEUKEMIA VIRUS 1; IN VITRO STUDY; LONG TERMINAL REPEAT; MONOTHERAPY; NONHUMAN; PROMOTER REGION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; WILD TYPE; BIOSYNTHESIS; DRUG ANTAGONISM; DRUG EFFECT; GENE FUSION; GENETIC TRANSCRIPTION; GENETICS; HUMAN; PHYSIOLOGY; REPORTER GENE; RETROVIRUS;

HUMAN T-LYMPHOTROPIC VIRUS 1; MAMMALIA;

ARTIFICIAL GENE FUSION; CHLORAMPHENICOL O-ACETYLTRANSFERASE; DELTARETROVIRUS; GENES, REPORTER; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; NF-KAPPA B; PROTO-ONCOGENE PROTEINS C-MYB; SIROLIMUS; TERMINAL REPEAT SEQUENCES; TRANSCRIPTION, GENETIC;

EID: 34247349925     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-4-24     Document Type: Article

References (37)

1. Gessain A Barin F Vernant JC Gout O Maurs L Calender A de Thé G Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. The Lancet 1985 ii 407-409
2. Osame M Usuku K Izumo S Ijichi N Amitani H Igata A Matsumoto M Tara M HTLV-I-associated myelopathy, a new clinical entity. The Lancet 1986 i 1031-1032
3. Poiesz B Ruscetti FW Gazdar AF Bunn PA Minna JD Gallo RC Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proceedings of the National Academy of Sciences USA 1980 77 7415-7419
4. Yoshida M Miyoshi I Hinuma Y Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proceedings of the National Academy of Sciences USA 1982 79 2031-2035 10.1073/pnas.79.6.2031
5. Höllsberg P Wucherpfennig KW Ausubel LJ Calvo V Bierer BE Hafler DA Characterization of HTLV-I in vivo infected T cell clones. Journal of Immunology 1992 148 3256-3263
6. Wucherpfennig KW Höllsberg P Richardson JH Benjamin D Hafler DA T-cell activation by autologous human T-cell leukemia virus type I-infected T-cell clones. Proceedings of the National Academy of Sciences USA 1989 89 2110-2114
7. Abraham RT Wiederrecht GJ Immunopharmacology of rapamycin. Annual Reviews in Immunology 1996 14 483-510 10.1146/annurev.immunol.14.1.483
8. Raught B Gingras AC Sonenberg N The target of rapamycin (TOR) proteins Proc Natl Acad Sci U S A 2001 98 7037-7044 34619 11416184 10.1073/ pnas.121145898
9. Wullschleger S Loewith R Hall MN TOR signaling in growth and metabolism Cell 2006 124 471-484 10.1016/j.cell.2006.01.016 16469695
10. Pende M Um SH Mieulet V Sticker M Goss VL Mestan J Mueller M Fumagalli S Kozma SC Thomas G S6K1(-/-)/S6K2(-/-) mice exhibit perinatal lethality and rapamycin-sensitive 5 '-terminal oligopyrimidine mRNA translation and reveal a mitogen-activated protein kinase-dependent S6 kinase pathway Molecular and Cellular Biology 2004 24 3112-3124 10.1128/ MCB.24.8.3112-3124.2004
11. Ruvinsky I Sharon N Lerer T Cohen H Stolovich-Rain M Nir T Dor Y Zisman P Meyuhas O Ribosomal protein S6 phosphorylation is a determinant of cell size and glucose homeostasis10.1101/gad.351605 Genes Dev 2005 19 2199-2211 1221890 16166381 10.1101/gad.351605
12. Holz MK Ballif BA Gygi SP Blenis J mTOR and S6K1 mediate assembly of the translation preinitiation complex through dynamic protein interchange and ordered phosphorylation events Cell 2005 123 569-580 10.1016/ j.cell.2005.10.024 16286006
13. Jeffries HBJ Fumagalli S Dennis PB Reinhard C Pearson RB Thomas G Rapamycin suppresses 5′ TOP mRNA translation through inhibition of p70s6k. The EMBO Journal 1997 16 3693-3704
14. Levy S Avni D Hariharan N Perry RP Meyuhas O Oligopyrimidine tract at the 5' end of mammalian ribosomal protein mRNAs is required for their translational control. Proceeding of the National Academy of Sciences USA 1991 88 3319-3323 10.1073/pnas.88.8.3319
15. Terada N Patel HR Takase K Kohno K Nairn AC Rapamycin selectively inhibits translation of mRNAs encoding elongation factors and ribosomal proteins. Proceedings of the National Academy of Sciences USA 1994 91 11477-11481 10.1073/pnas.91.24.11477
16. Rose NJ Lever AML The rapamycin sensitivity of human T-cell leukaemia virus type I-induced T-cell proliferation is mediated independently of the polypyrimidine motifs in the 5 ' long terminal repeat J Gen Virol 2001 82 435-439 11161283
17. Flint J Shenk T Viral transactivating proteins Annual Reviews in Genetics 1997 31 177-212
18. Bosselut R Duvall JF Gégonne A Bailly M Hémar A Brady J Ghysdael J The product of the c-ets-1 proto-oncogene and the related Ets2 protein act as transcriptional activators of the long terminal repeat of human T cell leukemia virus HTLV-1. The EMBO Journal 1990 9 3137-3144
19. Bosselut R Lim F Rommond PC Frampton J Brady J Ghysdael J Myb protein binds to multiple sites in the human T-cell lymphotropic virus type I long terminal repeat and transactivates LTR-mediated expression. Virology 1992 186 764-769 10.1016/0042-6822(92)90044-P
20. Dasgupta P Reddy CD Saikumar P Reddy EP The cellular proto-oncogene product Myb acts as transcriptional activator of the long terminal repeat of human T-lymphotropic virus type I. Journal of Virology 1992 66 270-276
21. Dittmer J Nordheim A Ets transcription factors and human disease. Biochimica et Biophysica Acta 1998 1377 F1-F12 10.1016/ S0304-419X(97)00039-5 9606973
22. Weston K Myb proteins in life, death and differentiation Curr Opin Genet Dev 1998 8 76-81 10.1016/S0959-437X(98)80065-8 9529609
23. Oh IH Reddy EP The myb gene family in cell growth, differentiation and apoptosis Oncogene 1999 18 3017-3033 10.1038/sj.onc.1202839 10378697
24. Colgin MA Nyborg JK The human T-cell leukemia virus type 1 oncoprotein tax inhibits the transcriptional activity of c-Myb through competition for the CREB binding protein J Virol 1998 72 9396-9399 110368 9765496
25. Nicot C Mahieux R Opavsky R Cereseto A Wolff L Brady JN Franchini G HTLV-I Tax transrepresses the human c-Myb promoter independently of its interaction with CBP or p300 Oncogene 2000 19 2155-2164 10.1038/ sj.onc.1203536 10815807
26. Nicot C Mahieux R Pise-Masison C Brady J Gessain A Yamaoka S Franchini G Human T-Cell Lymphotropic Virus Type 1 Tax Represses c-Myb-Dependent Transcription through Activation of the NF-κB Pathway and Modulation of Coactivator Usage Mol Cell Biol 2001 21 7391-7402 99912 11585920 10.1128/MCB.21.21.7391-7402.2001
27. Beimling P Moelling K Direct interaction of CREB protein with 21 bp Tax-response elements of HTLV-I LTR. Oncogene 1992 7 257-262
28. Jeang KT Functional activities of the human T-cell leukemia virus type I Tax oncoprotein: Cellular signaling through NF-kappa B Cytokine Growth Factor Rev 2001 12 207-217 10.1016/S1359-6101(00)00028-9 11325603
29. Toth CR Hostutler RF Baldwin ASJ Bender TP Members of the Nuclear Factor kappa B Family Transactivate the Murine c-myb Gene J Biol Chem 1995 270 7661-7671 10.1074/jbc.270.13.7661 7706314
30. Alexandre C Verrier B Four regulatory elements in the human c-fos promoter mediate transactivation by the HTLV-1 Tax protein. Oncogene 1991 6 543-551
31. Grolleau A Bowman J Pradet-Balade B Puravs E Hanash S Garcia-Sanz JA Beretta L Global and specific translational control by rapamycin in T cells uncovered by microarrays and proteomics J Biol Chem 2002 277 22175-22184 10.1074/jbc.M202014200 11943782
32. Phan SC Feeley B Withers D Boxer LM Identification of an inducible regulator of c-myb expression during T-cell activation Mol Cell Biol 1996 16 2387-2393 231227 8628306
33. Roy J Paquette JS Fortin JF Tremblay MJ The immunosuppressant rapamycin represses human immunodeficiency virus type 1 replication Antimicrob Agents Chemother 2002 46 3447-3455 128699 12384349 10.1128/ AAC.46.11.3447-3455.2002
34. Gewirtz A Anfossi G Venturelli D Valpreda S Sims R Calabretta B G1/S transition in normal human T-lymphocytes requires the nuclear protein encoded by c-myb. Science 1989 245 180-183 10.1126/science.2665077 2665077
35. Rohwer F Todd S McGuire KL The effect of IL-2 treatment on transcriptional attenuation in proto-oncogenes pim-1 and c-myb in human thymic blast cells J Immunol 1996 157 643-649 8752912
36. Rose NJ Richardson J Desselberger U Lever AML Viral inactivation in a proportion of HTLV-I-infected T-cell clones arises through naturally occurring mutations. Journal of General Virology 2000 81 97-104 10640546
37. Sambrook J Fritsch EF Maniatis T Molecular Cloning: A Laboratory Manual., Cold Spring Harbor Laboratory Press 2nd 1989